Imprimis Pharma (IMMY) Reports Q4 Loss of $0.30
Tweet
Share
E-mailGet Alerts IMMY Hot Sheet
Join SI Premium – FREE
Imprimis Pharma (NASDAQ: IMMY) reported Q4 EPS of ($0.30), versus ($0.21) reported last year.
For earnings history and earnings-related data on Imprimis Pharma (IMMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04
- RCM Technologies (RCMT) Tops Q2 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
